Stock-Based Compensation (Tables)
|
6 Months Ended |
Jul. 31, 2025 |
|---|
| Share-Based Payment Arrangement [Abstract] |
|
| Schedule of Share-Based Compensation Expense |
The following table summarizes the Company's stock-based compensation expense for equity classified awards for the periods presented: | | | | | | | | | | | | | | | | | | | | | | | | | Three months ended July 31, | | Six months ended July 31, | | (in thousands) | 2025 | | 2024 | | 2025 | | 2024 | | Equity classified awards: | | | | | | | | | Cost of revenue | $ | 729 | | | $ | 698 | | | $ | 1,400 | | | $ | 1,386 | | | Sales and marketing | 704 | | | 3,155 | | | 3,115 | | | 5,906 | | | Research and development | 3,818 | | | 2,607 | | | 6,952 | | | 5,390 | | | General and administrative | 7,711 | | | 5,873 | | | 14,154 | | | 11,716 | | | Total stock-based compensation expense | $ | 12,962 | | | $ | 12,333 | | | $ | 25,621 | | | $ | 24,398 | |
| | | | | | | | | | | | | | | | | | | | | | | | | Three months ended July 31, | | Six months ended July 31, | | (in thousands) | 2025 | | 2024 | | 2025 | | 2024 | | Liability classified awards: | | | | | | | | | Cost of revenue | $ | 225 | | | $ | — | | | $ | 716 | | | $ | — | | | Sales and marketing | 100 | | | — | | | 573 | | | — | | | Research and development | 514 | | | — | | | 1,201 | | | — | | | General and administrative | 54 | | | — | | | 235 | | | — | | | Total compensation expense | $ | 893 | | | $ | — | | | $ | 2,725 | | | $ | — | |
|
| Schedule of Stock Options Activity |
The following table summarizes the activity related to the Company's stock options: | | | | | | | | | | | | | | | | | | | | | | | | | Options Outstanding | | Outstanding Stock Options | | Weighted-Average Exercise Price | | Weighted-Average Remaining Contractual Life (in years) | | Aggregate Intrinsic Value
(in thousands) | Balance, January 31, 2025 | 1,566,134 | | | $ | 6.78 | | | 1.48 | | $ | 450 | | | Granted | — | | | $ | — | | | | | | | Exercised | (87,325) | | | $ | 5.03 | | | | | | | Forfeited or canceled | (45,600) | | | $ | 10.83 | | | | | | Balance, July 31, 2025 | 1,433,209 | | | $ | 6.75 | | | 0.97 | | $ | 2,044 | | | Vested and expected to vest | 1,433,209 | | | $ | 6.75 | | | 0.97 | | $ | 2,044 | | Exercisable, July 31, 2025 | 1,433,209 | | | $ | 6.75 | | | 0.97 | | $ | 2,044 | |
|
| Schedule of Restricted Stock and Restricted Stock Units |
The following table summarizes the activity related to the Company's restricted stock and restricted stock units ("RSUs"): | | | | | | | | | | | | | Outstanding | | Weighted-Average Grant Date Fair Value | Balance, January 31, 2025 | 10,315,199 | | | $ | 6.37 | | | Granted | 5,428,891 | | | $ | 7.59 | | | Vested and converted to shares | (3,958,322) | | | $ | 6.12 | | | Forfeited or canceled | (1,495,080) | | | $ | 6.53 | | Balance, July 31, 2025 | 10,290,688 | | | $ | 7.09 | |
|
| Schedule of Performance-Based Restricted Stock Units |
The following table summarizes the activity related to the Company’s PSUs: | | | | | | | | | | | | | Number of PSUs | | Weighted-Average Grant Date Fair Value | Balance, January 31, 2025 | 3,495,000 | | | $ | 5.97 | | | Granted | 995,000 | | | $ | 7.13 | | | Vested | (391,875) | | | $ | 5.69 | | | Forfeited or canceled | (303,125) | | | $ | 6.11 | | Balance, July 31, 2025 | 3,795,000 | | | $ | 6.29 | |
|